Literature DB >> 28596434

Treatment outcomes of MDR-TB and HIV co-infection in Europe.

Cecile Magis-Escurra1,2, Gunar Günther3,4,2, Christoph Lange5,4,6,7,2, Sofia Alexandru8, Neus Altet9, Korkut Avsar10, Didi Bang11, Raisa Barbuta12, Graham Bothamley13, Ana Ciobanu8, Valeriu Crudu8,14, Manfred Davilovits15, Martin Dedicoat16,17, Raquel Duarte18,19, Gina Gualano20, Heike Kunst21,22, Wiel de Lange23,24, Vaira Leimane25, Anne-Marie McLaughlin26, Inge Muylle27, Veronika Polcová28, Christina Popa29, Rudolf Rumetshofer30, Alena Skrahina31, Varvara Solodovnikova31, Victor Spinu29, Simon Tiberi22,32,33, Piret Viiklepp34, Frank van Leth35,36,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28596434     DOI： 10.1183/13993003.02363-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.

Authors:  D M Kokebu; S Ahmed; R Moodliar; C-Y Chiang; G Torrea; A Van Deun; R L Goodall; I D Rusen; S K Meredith; A J Nunn
Journal:  Int J Tuberc Lung Dis       Date:  2022-08-01       Impact factor: 3.427

Review 2.  Chronic Immune Activation in TB/HIV Co-infection.

Authors:  Riti Sharan; Allison N Bucşan; Shashank Ganatra; Mirko Paiardini; Mahesh Mohan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2020-04-22       Impact factor: 17.079

3.  Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.

Authors:  Elvis Dzelamonyuy Chem; Marie Claire Van Hout; Vivian Hope
Journal:  BMC Infect Dis       Date:  2019-08-16       Impact factor: 3.090

Review 4.  Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives.

Authors:  Abhijeet Singh; Rajendra Prasad; Viswesvaran Balasubramanian; Nikhil Gupta
Journal:  HIV AIDS (Auckl)       Date:  2020-01-13

5.  Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.

Authors:  Arto Yuwono Soeroto; Chica Pratiwi; Prayudi Santoso; Bony Wiem Lestari
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

6.  Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: A countrywide 5-year retrospective study.

Authors:  Joseph Baruch Baluku; Bridget Nakazibwe; Joshua Naloka; Martin Nabwana; Sarah Mwanja; Rose Mulwana; Mike Sempiira; Sylvia Nassozi; Febronius Babirye; Carol Namugenyi; Samuel Ntambi; Sharon Namiiro; Felix Bongomin; Richard Katuramu; Irene Andia-Biraro; William Worodria
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-01-27

7.  Factors associated with treatment outcomes of patients with drug-resistant tuberculosis in China: A retrospective study using competing risk model.

Authors:  Zhiwei Li; Keng Lai; Tiegang Li; Zhuochen Lin; Zichao Liang; Yuhua Du; Jinxin Zhang
Journal:  Front Public Health       Date:  2022-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.